Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797654 · ClinicalTrials.gov registry record · NA
HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse
A NA study, sponsored by Fenway Community Health.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT00797654: Completed NA study, sponsored by Fenway Community Health.
NCT00797654 is a NA study that has completed, run by Fenway Community Health. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00797654, a NA study, has completed, sponsored by Fenway Community Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will develop a therapy for men who have sex with men who also have a history of childhood sexual abuse to reduce behaviors that put them at a high risk of HIV infection.
Primary Outcome
For both the Treatment (Cognitive Processing Therapy with Information Motivation Behavior) and Control arms, participants will self-report sexual risk taking at baseline, 3-month post baseline, and at 6 and 9-month follow-ups (after enrollment).
Interventions
- BEHAVIORAL Information-motivation-behavior skills and cognitive processing therapy
- BEHAVIORAL Pre and Post HIV-Test Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT00797654 record still lists
NCT00797654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Information-motivation-behavior skills and cognitive processing therapy is the first listed.
NCT00797654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00797654 about?
NCT00797654 is a clinical study titled "HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse". This study will develop a therapy for men who have sex with men who also have a history of childhood sexual abuse to reduce behaviors that put them at a high risk of HIV infection.
What is the current status of trial NCT00797654?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2008-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00797654?
The interventions under investigation include: Information-motivation-behavior skills and cognitive processing therapy (BEHAVIORAL), Pre and Post HIV-Test Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00797654?
This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00797654's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia